EUVIMEDEUVIMED entdecken
Crossref

Ribozyme-activated mRNA trans-ligation enables large gene delivery to treat muscular dystrophies

Sean R Lindley iD, Kadiam C Venkata Subbaiah iD, Fnu Priyanka iD, Pornthida Poosala iD, Yijie Ma iD, Leila Jalinous, Jason A West iD, William A Richardson, Tamlyn N Thomas iD, Douglas M Anderson iD

Science · 2024

DOI: 10.1126/science.adp8179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, 2024. Verfasst von Sean R Lindley und 9 weiteren Autor:innen. Beteiligte Einrichtung: Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA. Hauptthemen laut MEDLINE: Dysferlin, Genetic Therapy, Muscular Dystrophies, RNA, Catalytic. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ribozymes are small catalytic RNA sequences capable of nucleotide-specific self-cleavage found widespread in nature. Ribozyme cleavage generates distinct 2′,3′-phosphate and 5′-hydroxyl termini that resemble substrates for recently characterized RNA repair pathways in cells. We report that ribozyme cleavage of two separate mRNAs activated their scarless trans-ligation and translation into full-length protein in eukaryotic cells, a process that we named StitchR (for Stitch RNA). Optimization of StitchR activity in mammalian cells resulted in a ~900-fold increase in protein expression that approached levels observed for genes expressed from single vectors. We demonstrate that StitchR can be harnessed for effective dual adeno-associated virus gene therapies to correct muscular dystrophies by restoring large functional muscle proteins to endogenous levels in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysferlinGenetic TherapyMuscular DystrophiesRNA, CatalyticRNA, MessengerAnimalsHumansMiceDependovirusGene Transfer TechniquesGenetic VectorsHEK293 CellsProtein BiosynthesisRNA CleavageMaleFemaleMice, Inbred C57BL

Substanzen

DYSF protein, humanDysferlinRNA, CatalyticRNA, Messenger

Autor:innen und Institutionen

  • Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
  • Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
  • Center for RNA Biology: From Genome to Therapeutics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
  • CANbridge Pharmaceuticals, Burlington, MA 01803, USA.

ORCID-Profile: Sean R Lindley, Kadiam C Venkata Subbaiah, Fnu Priyanka, Pornthida Poosala, Yijie Ma, Jason A West, Tamlyn N Thomas, Douglas M Anderson

Zitieren

APA

Lindley, S. R., Subbaiah, K. C. V., Priyanka, F., Poosala, P., Ma, Y., Jalinous, L., West, J. A., Richardson, W. A., Thomas, T. N., & Anderson, D. M. (2024). Ribozyme-activated mRNA trans-ligation enables large gene delivery to treat muscular dystrophies. Science. https://doi.org/10.1126/science.adp8179

Vancouver

Lindley SR, Subbaiah KCV, Priyanka F, Poosala P, Ma Y, Jalinous L, et al. Ribozyme-activated mRNA trans-ligation enables large gene delivery to treat muscular dystrophies. Science. 2024. doi:10.1126/science.adp8179

BibTeX
@article{Lindley2024,
  author = {Lindley, Sean R and Subbaiah, Kadiam C Venkata and Priyanka, Fnu and Poosala, Pornthida and Ma, Yijie and Jalinous, Leila and West, Jason A and Richardson, William A and Thomas, Tamlyn N and Anderson, Douglas M},
  title = {Ribozyme-activated mRNA trans-ligation enables large gene delivery to treat muscular dystrophies},
  journal = {Science},
  year = {2024},
  doi = {10.1126/science.adp8179}
}
Kostenlos starten →